Honeywell International Inc. 2002 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2002. Honeywell International Inc. is a diversified technology and manufacturing company operating through four reportable segments: Aerospace, Automation and Control Solutions, Specialty Materials, and Transportation and Power Systems. The company serves global customers in aerospace, building control, automotive, and industrial sectors. As of December 31, 2002, the company employed approximately 108,000 people, with roughly 63,000 located in the United States.
Key Financial Metrics
The filing text incorporates detailed financial statements by reference and does not explicitly state total revenue, net income, or cash flow figures in the provided narrative. However, the following specific metrics are disclosed:
- Research and Development (R&D) Expense: $757 million in 2002 (down from $832 million in 2001).
- Customer-Sponsored R&D: $603 million in 2002.
- Backlog: Total backlog was $7,332 million at year-end 2002, compared to $7,178 million in 2001. Approximately $6,194 million is expected to be filled in 2003.
- U.S. Government Sales: $2,277 million in 2002 (including $1,833 million to the Department of Defense).
- Market Value: Aggregate market value of voting stock held by nonaffiliates was approximately $28.9 billion as of June 30, 2002.
- Allowance for Doubtful Accounts: $147 million at December 31, 2002.
Material Changes and Operational Highlights
The 2002 operating environment was significantly impacted by the aftermath of the September 11, 2001 terrorist attacks, which caused an abrupt downturn in the aviation industry. This continued to adversely affect the Aerospace segment throughout 2002. In response, management accelerated cost-reduction actions. R&D expenses decreased primarily due to lower spending in the Aerospace segment resulting from program completions and fewer new program launches by original equipment manufacturers.
U.S. defense spending increased in 2002 and was expected to rise in 2003. The company noted that while backlog increased slightly year-over-year, it is not a reliable indicator of future sales due to the potential for customer cancellations.
Guidance, Risks, and Contingencies
Legal Proceedings and Asbestos Liabilities: The most significant financial contingency involves asbestos-related litigation.
- NARCO (North American Refractories Company): In Q4 2002, Honeywell recorded a charge of $1.4 billion for NARCO-related asbestos litigation, net of estimated insurance recoveries of $1.8 billion. This covers current claims and projected future claims through 2018. Negotiations are ongoing to establish a trust and a permanent channeling injunction.
- Bendix Friction Materials: In Q4 2002, a charge of $167 million was recorded related to the sale of the Bendix business to Federal-Mogul Corp. This includes a reserve for asbestos liabilities net of insurance. Honeywell entered a letter of intent to sell the business in exchange for a permanent injunction against future asbestos claims.
- Shareowner Litigation: Several class action lawsuits regarding alleged false financial statements are pending. No provision has been made for these contingent liabilities as the company expects to prevail or resolve via mediation.
- Government Contracts: Dependence on Congressional appropriations and changes in procurement regulations.
- International Operations: Exposure to currency fluctuations, trade restrictions, and political instability.
- Raw Materials: Dependence on petroleum byproducts for Specialty Materials; prolonged price increases could adversely affect results.
Investor Verification Checklist
- Verify the final terms and regulatory approval of the Bendix Friction Materials sale to Federal-Mogul to confirm the permanent channeling injunction against asbestos claims.
- Monitor the progress of the NARCO reorganization plan and the establishment of the 524(g) trust to ensure the $1.4 billion reserve remains adequate.
- Review the 2002 Annual Report to Shareowners (incorporated by reference) for the full Consolidated Statement of Operations to obtain total revenue, net income, and cash flow figures not explicitly detailed in this text.
- Assess the impact of commercial aviation recovery on the Aerospace segment's backlog and future sales, given the historical sensitivity to flight hours.
- Confirm the status of insurance recoveries related to asbestos claims, particularly regarding disputes with carriers in the London excess market.